Together, these results indicate a detrimental effect of AT1R signalling in the setting of ischaemic stroke through mechanisms including neuroinflammation, ROS generation, apoptosis and neurodegeneration, all of which are independent of BP yet clinically, systemic blockade of AT1R has not been shown to consistently improve stroke outcome or risk. The gene discussed is AGTR1; the disease is Stroke.